GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

Zealand Pharma A/S ZEAL.CO · DKK

Health Care · Nasdaq Copenhagen · 🇩🇰 Denmark

Compare

245.00

+5.20%

Close of 9 Nov 2026, in DKK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Zealand Pharma A/S — daily ZEAL

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Zealand Pharma A/S on TradingView ↗
Market value
DKK 16.28bn
Last close × shares
Volume
627.1k
Shares, 9 Nov 2026
Price to earnings
2.4

About Zealand Pharma A/S

Its shares trade on Nasdaq Copenhagen under the ticker ZEAL.CO. It has been listed since 1 November 2010. In the fiscal year to 31 December 2025, it reported revenue of DKK 9.21bn and net income of DKK 6.46bn. At that date it held total assets of DKK 16.46bn and shareholders' equity of DKK 14.83bn.

Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. The firm's pipeline comprises two implementation areas: Cardio-metabolic diseases and Other indications. The Cardio-metabolic diseases area includes medicines for diabetes and obesity treatment, such as Lyxumia (Lixisenatide), Lyxumia/Lantus, ZP2929 and Danegaptide. The Other indications area offers ZP1848, Elsiglutide and ZP1480 (ABT-719) drugs for inflammatory bowel disease, chemotherapy-induced diarrhea and acute kidney injury treatment. Furthermore, the Company collaborates with a number of partners, such as Sanofi, Helsinn, Boehringer Ingelheim, Abbvie and Eli Lilly.

Figures and description from our data supplier, not checked against the company's own report.

More about Zealand Pharma A/S →

Latest on Zealand Pharma A/S

Our reporting

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -10.39 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Zealand Pharma A/S's ticker?

Zealand Pharma A/S trades as ZEAL.CO on Nasdaq Copenhagen, under ISIN DK0060257814.

What was Zealand Pharma A/S's last closing price?

245.00 on 9 Nov 2026. The figure is in DKK and is never converted.

When does Zealand Pharma A/S next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.